studied foldamers. Of particular interest in this respect are
peptoids, i.e., oligo-N-substituted glycines, as these biomi-
metic oligomers have been widely used both as products in
combinatorial efforts7 and as foldamers. Peptoids with
R-chiral substituents on the nitrogen atom have been shown
to fold into helical structures,8 and several interesting
biological applications have been reported on the basis of
this property.9
â-Peptoids, i.e., oligomers with a backbone composed of
an unsubstituted â-amino acid â-Ala and with a side chain
anchored to the amide nitrogen, were first described by
Hamper et al. in 1998.10 This report described the synthesis
of â-peptoid dimers and trimers with nonchiral substituents
on the nitrogen atom. To the best of our knowledge, no
synthesis or structural investigation of â-peptoids with
R-chiral N-substituents has been reported. Although the
resulting â-peptoid would have three rotatable bonds in the
backbone, and consequently an expected low tendency to
adopt a folded conformation, we found it valuable to
investigate the influence of R-chiral N-substituents on the
structure of â-peptoids, especially considering the large
impact of such groups on the structure of normal R-peptoids
and the large interest in â-peptides.2,4 Herein, we report our
efforts to develop a practical solid-phase synthesis of
â-peptoids with R-chiral aromatic N-substituents (Figure 1)
a high excess of amines (up to 20 equiv) and very long
reaction times (up to 72 h) that preclude synthesis of longer
derivatives in a reasonable time. In contrast, Zuckermann
and co-workers11 invented a submonomer method for syn-
thesis of R-peptoids where each cycle of monomer addition
consists of two steps: acylation of the secondary amine by
an R-halogenated acyl donor followed by nucleophilic dis-
placement of the halogen by the next amine. Both these steps
require short reaction times (90 min), and relatively long
R-peptoid chains can be synthesized by this methodology.
â-Peptoids with R-chiral N-substituents are expected to
be more difficult to synthesize due to low reactivity of the
secondary amine in the acylation step as well as to steric
repulsions during the nucleophilic addition of the R-branched
side chain. In the search of good experimental procedures
to synthesize â-peptoids with R-branched aromatic side
chains, solution-phase chemistry was initially employed.
First, we focused on utilizing the nucleophilic displacement
reaction of Zuckerman in the synthesis of â-peptoids
(Scheme 1, top). Consequently, â-halogenated amides
Scheme 1. Solution-Phase Synthesis of Protected â-Peptoid 5
Figure 1. Structures of â-peptoids 1a-j and N-acetylated monomer
2, all possessing R-chiral aromatic N-substituents.
3a-c12 were treated with (S)-1-phenyl ethylamine in 1 mL
of solvent12 and stirred at 55 °C for 2-4 h. The reactions
were monitored by analytical reversed-phase HPLC-MS, and
the conversions were determined by integration of the UV
trace (Table 1). As expected, the chloride derivative 3a was
less reactive than the bromine and iodine analogues 3b and
3c (which had similar reactivity). Variation of the reaction
media revealed that 20% H2O in THF was one of the best
solvent systems tested. The HPLC-MS analyses also revealed
that the reaction conditions caused major elimination of the
â-halogen to give the R,â-unsaturated amide 412 in situ.
Employing 4 itself as a reactant provided the product 5 in
rates and yields similar to those for the halogen derivatives.
Thus, we next focused our attention on the Hamper method,
using acryloyl chloride as the acylating agent, and tried to
and an investigation concerning the folding propensities of
such molecules by circular dichroism (CD) spectroscopy.
For the synthesis of â-peptoids, Hamper developed a two-
step solid-phase methodology involving first acryloyl chlo-
ride as acylating agents to generate acrylamide resins,
followed by Michael addition of a primary amine to the R,â-
unsaturated system to generate the secondary amine.10 This
method was applied successfully for the synthesis of â-pep-
toids containing 2-3 residues; still, this procedure required
(6) Smith, A. B.; Favor, D. A.; Sprengler, P. A.; Guzman, M. C.; Carroll,
P. J.; Furst, G. T.; Hirschmann, R. Bioorg. Med. Chem. 1999, 7, 9.
(7) (a) Simon, R. J.; Kania, R. S.; Zuckermann, R. N.; Huebner, V. D.;
Jewell, D. A. et al. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 9367. (b)
Zuckermann, R. N.; Martin, E. J.; Spellmeyer, D. C.; Stauber, G. B.;
Shoemaker, K. R. et al. J. Med. Chem. 1994, 37, 2678.
(8) (a) Kirshenbaum, K.; Barron, A. E.; Goldsmith, R. A.; Armand, P.;
Bradley, E. K.; Truong, K. T. V.; Dill, K. A.; Cohen, F. E.; Zuckermann,
R. N. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 4303. (b) Wu, C. W.;
Kirshenbaum, K.; Sanborn, T. J.; Patch, J. A.; Huang, K.; Dill, K. A.;
Zuckermann, R. N.; Barron, A. E. J. Am. Chem. Soc. 2003, 125, 13525.
(9) Patch, J. A.; Barron, A. E. J. Am. Chem. Soc. 2003, 125, 12092.
(10) Hamper, B. C.; Kolodziej, S. A.; Scates, A. M.; Smith, R. G.; Cortez,
E. J. Org. Chem. 1998, 63, 708.
(11) Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H. J.
Am. Chem. Soc. 1992, 114, 10646.
(12) For further details, see Supporting Information.
(13) Some examples: (a) Bartoli, G.; Bartolacci, M.; Bosco, M.; Foglia,
G.; Giuliani, A.; Marcantoni, E.; Sambri, L.; Torregiani, E. J. Org. Chem.
2003, 68, 4594. (b) Enders, D.; Wallert, S.; Runsink, J. Synthesis 2003, 12,
1856. (c) Yadav, J. S.; Abraham, S.; Reddy, B. V. S.; Sabitha, G. Synthesis
2001, 14, 2165.
4534
Org. Lett., Vol. 8, No. 20, 2006